SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

CAMPOS HERNANDEZ, Derbis. Aplicación de la espectrometría de masas en tandem en el tamiz neonatal de los errores innatos del metabolismo. Acta bioquím. clín. latinoam. [online]. 2012, vol.46, n.2, pp. 195-204. ISSN 0325-2957.

    1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Paediatrics 1963; 32(3): 338-43. [ Links ]

    2. Pmpols T. Neonatal screening. Turk J Pediatr 2003; 45(2): 87-94. [ Links ]

    3. Dhondt JL. Expanded newborn screening: social and ethical issues. J Inherit Metab Dis 2010; 33(Suppl 2): S211-17. [ Links ]

    4. Rinaldo P, Hahn SH, Matern D. Inborn errors of amino acid, organic acid, and fatty acid metabolism. En: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th. ed. Philadelphia: W.B. Saunders; 2005. p. 2207-47. [ Links ]

    5. Lo SF, Young V, Rhead WJ. Identification of urine organic acids for the detection of inborn errors of metabolism using urease and gas chromatography-mass spectrometry (GC-MS). Methods Mol Biol 2010; 603: 433-43. [ Links ]

    6. Wajner M, Raymond K, Barschak A, Luft AP, Ferreira G, Domingues G, et al. Detection of organic acidemias in Brazil. Arch Med Res 2002; 33(6): 581-5. [ Links ]

    7. Kuhara T. Diagnosis and monitoring of inborn errors of metabolism using urease-pretreatment of urine, isotope dilution, and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 781(1-2): 497-517. [ Links ]

    8. Yu CL, Gu XF. Newborn screening of inherited metabolic diseases by tandem mass spectrometry. Beijing Da Xue Xue Bao 2006; 38(1): 103-6. [ Links ]

    9. Wilcken B, Wiley V. Newborn screening. Pathology 2008; 40(2): 104-15. [ Links ]

    10. De Jesús VR, Chace DH, Lim TH, Mei JV, Hannon WH. Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. Clin Chim Acta 2010; 411(9-10): 684-9. [ Links ]

    11. Chace DH, Kalas TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 2005; 38(4): 296-309. [ Links ]

    12. Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol Biol 2010; 603: 423-31. [ Links ]

    13. Chernushevich IV, Loboda AV, Thomson BA. An introduction to quadrupole-time-of-flight mass spectrometry. J Mass Spectrom 2001; 36(8): 849-65. [ Links ]

    14. McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007; 44(4): 899-925. [ Links ]

    15. Mei JV, Alexander JR, Adam BW, Hannon WHl. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001; 131(5): 1631S-6S. [ Links ]

    16. Torres E, Baloy A, Frómeta A, Fernández L. Determinación de fenilalanina y galactosa total a partir de una muestra de sangre seca en papel de filtro: aplicación al tamizaje neonatal. Biomédica 2002; 22(1): 22-9. [ Links ]

    17. Espada M, Dulín E. Procedimiento para la obtención y recogida de especímenes de sangre sobre papel de filtro en los programas de detección precoz neonatal de errores congénitos del metabolismo. Química Clínica 2001; 20: 81-8. [ Links ]

    18. Khalid JM, Oerton J, Besley G, Dalton N, Downing M, Green A, et al. Relationship of octanoylcarnitine concentrations to age at sampling in unaffected newborns screened for medium-chain acyl-CoA dehydrogenase deficiency. Clin Chem 2010; 56(6): 1015-21. [ Links ]

    19. Strnadová KA, Holub M, Mhl A, Heinze G, Ratschmann R, Mascher H, et al. Long-term stability of amino acids and acylcarnitines in dried blood spots. Clin Chem 2007; 53(4): 717-22. [ Links ]

    20. Chace DH, Adam BW, Smith SJ, Alexander JR, Hillman SL, Hannon WH. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clin Chem 1999; 45(8 Pt 1): 1269-77. [ Links ]

    21. Trinh MU, Blake J, Harrison JR, Gerace R, Ranieri E, Fletcher JM, et al. Quantification of glutamine in dried blood spots and plasma by tandem mass spectrometry for the biochemical diagnosis and monitoring of ornithine transcarbamylase deficiency. Clin Chem 2003; 49(4): 681-4. [ Links ]

    22. Chace DH, Millington DS, Hillman SL. The role of tandem mass spectrometry in reducing the number of false positive and false negative results in the diagnosis of metabolic disease from dried blood spots. En: Pass K, Levy H, editors. Early hospital discharge: impact on newborn screening. Council of regional networks for genetics services. Atlanta: Emory University School of Medicine; 1995. p. 272-83. [ Links ]

    23. Fingerhut R, Ensenauer R, Rschinger W, Arnecke R, Olgemller B, Roscher AA. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. Anal Chem 2009; 81(9): 3571-5. [ Links ]

    24. Santer R, Fingerhut R, Lssker U, Wightman PJ, Fitzpatrick DR, Olgemller B, et al. Tandem mass spectrometric determination of malonylcarnitine: diagnosis and neonatal screening of malonyl-CoA decarboxylase deficiency. Clin Chem 2003; 49(4): 660-2. [ Links ]

    25. Kobayashi H, Hasegawa Y, Endo M, Purevsuren J, Yamaguchi S. A retrospective ESI-MS/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood. J Inherit Metab Dis 2007; 30(4): 606. [ Links ]

    26. Moammar H, Cheriyan G, Mathew R, Al-Sannaa N. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008. Ann Saudi Med 2010; 30(4): 271-7. [ Links ]

    27. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990; 13(3): 321-4. [ Links ]

    28. Garg U, Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Clin Biochem 2006; 39(4): 315-32. [ Links ]

    29. Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH, et al. Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clin Chem 2000; 46(1): 126-8. [ Links ]

    30. Holub M, Tuschl K, Ratschmann R, Strnadová KA, Mhl A, Heinze G, et al. Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. Clin Chim Acta 2006; 373(1-2): 27-31. [ Links ]

    31. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003; 49(11): 1797-817. [ Links ]

    32. Rashed MS, Rahbeeni Z, Ozand PT. Application of electrospray tandem mass spectrometry to neonatal screening. Semin Perinatol 1999; 23(2): 183-93. [ Links ]

    33. Manning NJ, Maloney M, Olpin SE, Pollitt RJ, Bonham JR, Heap SJ, et al. Analysis of dicarboxylic-acylcarnitines by electrospray-tandem mass spectrometry (ESI-MSMS) without derivatisation. Implications for neonatal screening and routine diagnosis. J Inherit Metab Dis 2001; 24(1 Suppl):6. [ Links ]

    34. Schulze A, Schmidt C, Kohlmller D, Hoffmann GF, Mayatepek E. Accurate measurement of free carnitine in dried blood spots by isotope-dilution electrospray tandem mass spectrometry without butylation. Clin Chim Acta 2003; 335(1-2): 137-45. [ Links ]

    35. Johnson DW. Analysis of amino acids as formamidene butyl esters by electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2001; 15(22): 2198-205. [ Links ]

    36. Turgeon CT, Magera MJ, Cuthbert CD, Loken PR, Gavrilov DK, Tortorelli S, et al. Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry. Clin Chem 2010; 56(11): 1686-95. [ Links ]

    37. Zoppa M, Gallo L, Zacchello F, Giordano G. Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC-ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 83(1-2): 267-73. [ Links ]

    38. Bodamer OA, Mhl A. Analysis of acylcarnitine ester for the diagnosis of inborn errors of metabolism using tandem mass-spectrometry. Chem Month 2005; 136: 1293-7. [ Links ]

    39. Nagy K, Takáts Z, Pollreisz F, Szabó T, Vékey K. Direct tandem mass spectrometric analysis of amino acids in dried blood spots without chemical derivatization for neonatal screening. Rapid Commun Mass Spectrom 2003; 17(9): 983-90. [ Links ]

    40. Ho CS, Lam CW, Chan MH, Cheung RC, Law LK, Lit LC, et al. Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev 2003; 248(1): 3-12. [ Links ]

    41. Carpenter KH, Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clin Chim Acta 2002; 322(1-2): 1-10. [ Links ]

    42. Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, et al. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 776(1): 39-48. [ Links ]

    43. Schulze A, Lindner M, Kohlmller D, Olgemller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003; 111(6 Pt 1): 1399-406. [ Links ]

    44. Corso G, Paglia G, Garofalo D, D'Apolito O. Neutral loss analysis of amino acids by desorption electrospray ionization using an unmodified tandem quadrupole mass spectrometer. Rapid Commun Mass Spectrom 2007; 21(23): 3777-84. [ Links ]

    45. Gogichaeva NV, Williams T, Alterman MA. MALDI TOF/TOF tandem mass spectrometry as a new tool for amino acid analysis. J Am Soc Mass Spectrom 2007; 18(2): 279-84. [ Links ]

    46. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003; 348(23): 2304-12. [ Links ]

    47. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47(7): 1166-82. [ Links ]

    48. Kushnir MM, Komaromy-Hiller G, Shushan B, Urry FM, Roberts WL. Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin Chem 2001; 47(11): 1993-2002. [ Links ]

    49. Osorio JH, Pourfarzam M. Plasma free and total carnitine measured in children by tandem mass spectrometry. Braz J Med Biol Res 2002; 35(11): 1265-71. [ Links ]

    50. Oglesbee D, Sanders KA, Lacey JM, Magera MJ, Casetta B, Strauss KA, et al. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clin Chem 2008; 54(3): 542-9. [ Links ]

    51. Qu J, Wang Y, Luo G, Wu Z, Yang C. Validated quantitation of underivatized amino acids in human blood samples by volatile ion-pair reversed-phase liquid chromatography coupled to isotope dilution tandem mass spectrometry. Anal Chem 2002; 74(9): 2034-40. [ Links ]

    52. Campos Hernández D. Tamizaje neonatal por espectrometría de masas en tándem: actualización. Rev Panam Salud Pública 2010; 27(4): 309-18. [ Links ]

    53. Loukas YL, Soumelas GS, Dotsikas Y, Georgiou V, Molou E, Thodi G, et al. Expanded newborn screening in Greece: 30 months of experience. J Inherit Metab Dis 2010 Aug 19. Disponible en URL: http://www.springerlink.com/content/yl6v48686h2t1448/ (Fecha de acceso: 25 de octubre de 2010). [ Links ]

    54. Torres-Sepúlveda MR, Martínez-de Villarreal LE, Esmer C, González-Alanís R, Ruiz-Herrera C, Sánchez-Peña A, et al. Tamiz metabólico neonatal por espectrometría de masas en tándem: dos años de experiencia en Nuevo León, México. Salud Publica Mex 2008; 50(3): 200-6. [ Links ]

    55. Marín Soria JL, Aldamiz-Echevarria L, Castiñeiras Ramos DE, Dalmau Serra J, Fernández Sánchez A, González Lamuño D, et al. Programas de cribado neonatal en España: actualización y propuestas de futuro. Asociación Española para el Estudio de Errores Congénitos del Metabolismo; Asociación Española de Pediatría, Sección de Errores Innatos del Metabolismo; Sociedad Española de Química Clínica y Patología Molecular, Comisión de Diagnóstico Perinatal. 31 de mayo de 2009. Disponible en URL: http://www.ae3com.org/noticias/programascribado-neonatal.pdf (Fecha de acceso: 16 de febrero de 2010). [ Links ]

    56. Yamaguchi S. Newborn screening in Japan: restructuring for the new era. Ann Acad Med Singapore 2008; 37(12 Suppl): 13-5. [ Links ]

    57. Chace DH, Millington DS, Hillman SL. The role of tandem mass spectrometry in reducing the number of false positive and false negative results in the diagnosis of metabolic disease from dried blood spots. En: Pass K, Levy H, editors. Early hospital discharge: impact on newborn screening. Atlanta: Emory University School of Medicine; 1995. p. 272-83. [ Links ]

    58. De Jesús VR, Mei JV, Bell CJ, Hannon WH. Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention. Semin Perinatol 2010; 34(2): 125-33. [ Links ]

    59. Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis 2010; 33(5): 521-6. [ Links ]

    60. Centers for Disease Control and Prevention. Newborn screening quality assurance program. Quality control midyear report. Atlanta: Centers for Disease Control and Prevention (CDC), Association of Public Health Laboratories. 2010 Jun; 21 (1). Disponible en URL: http://www.cdc.gov/labstandards/pdf/nsqap/nsqap_qcmidyearreport_2010.pdf] (Fecha de acceso: 25 de agosto de 2010). [ Links ]